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Infection of mouse trigeminal ganglia by herpes simplex virus induces cytokine expression that persists long after
infectious virus or viral antigens become undetectable. To examine mechanisms underlying this phenomenon, we used a
thymidine kinase mutant, dlsptk, which fails to replicate in ganglia and does not reactivate upon ganglionic explant. Using
quantitative reverse transcriptase–polymerase chain reaction assays, we found that levels of interferon-g and tumor necrosis
factor-a transcripts in dlsptk-infected ganglia were lower than those in wild type-infected ganglia, but were significantly
(eight- to 10-fold) higher than those in mock-infected ganglia from Day 3 to Day 100 postinfection. We also studied
latency-associated transcript (LAT) negative mutants that exhibit increased expression of productive cycle transcripts in
ganglia. Ganglia infected with these mutants contained levels of cytokine transcripts similar to those in wild type-infected
ganglia; any increases in viral antigen expression mediated by the LAT deletion were not accompanied by increased cytokine
expression. Thus, neither viral replication, the ability to reactivate, nor LAT expression in ganglia is required for persistent
elevated cytokine expression. The results provide indirect evidence that low-level expression of viral productive cycle genes
in neurons can provide signals that elicit cytokine expression. © 2000 Academic PressINTRODUCTION
Certain viruses can establish and maintain latent in-
fections in the face of the host immune response. De-
spite years of investigation, interactions between the
immune system and latent viruses are poorly under-
stood. For herpes simplex virus type 1 (HSV-1), following
infection of mice on the cornea, the virus gains access to
nerve terminals and is transmitted to neuronal cell bod-
ies in the trigeminal ganglion, where viral replication may
occur for a few days (acute ganglionic replication). Sub-
sequently, the virus establishes a latent infection in neu-
rons in which infectious virus and viral antigens are not
detected. As part of the host immune response to these
events, large numbers of macrophages and T cells infil-
trate the ganglion and high levels of cytokines are pro-
duced during acute ganglionic replication. Interestingly,
cytokine-expressing infiltrating cells and elevated levels
of cytokines and cytokine transcripts persist in the gan-
glion long after infectious virus or viral antigens become
undetectable (Cantin et al., 1995; Halford et al., 1996; Liu
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207et al., 1996; Shimeld et al., 1997). It has been hypothe-
sized that persistent expression of cytokines could help
maintain latency by effects on HSV gene expression
(Cantin et al., 1995; Halford et al., 1996; Liu et al., 1996).
However, this persistence is surprising because, gener-
ally, the cellular immune response responsible for cyto-
kine production wanes rapidly following disappearance
of virus and viral antigens (Doherty and Ahmed, 1999;
Slifka et al., 1999).
One hypothesis to explain this phenomenon is that
low-level production of viral particles (i.e., reactivation),
which would depend on viral DNA replication, is respon-
sible for persistent cytokine expression. Consistent with
this hypothesis, it was previously reported that cytokine
expression in ganglia of mice latently infected with
HSV-1 strain McKrae is sensitive to the anti-HSV drug
acyclovir, an inhibitor of viral DNA synthesis (Halford et
al., 1997).
An alternate hypothesis is that HSV does not reacti-
vate from latent infection in mice, but nevertheless ex-
presses antigen in amounts that, although too low to
detect, are nonetheless sufficient to elicit continuing ex-
pression of cytokine genes. Such antigen could come
from two sources. One source is the latency-associated
transcript (LAT) transcription unit, which is abundantly
expressed during latency. Arguing against this source,
ganglia infected with a LAT deletion mutant of strain
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208 CHEN ET AL.McKrae exhibited elevated cytokine expression 60 days
postinfection (p.i.) (Carr et al., 1998). In this study, how-
ver, later time points were not examined and spontane-
us reactivation of this mutant in mice was not excluded.
ntigen could also arise from genes ordinarily expressed
uring the viral productive cycle. Consistent with this
ypothesis, transcripts from genes encoding the proteins
CP4 and thymidine kinase (TK), which are ordinarily
xpressed during productive HSV infection, can be de-
ected in ganglia latently infected with HSV using sensi-
ive reverse transcriptase–polymerase chain reaction
RT-PCR) methods (Kramer and Coen, 1995; Chen et al.,
1997).
To investigate these various hypotheses, we took a
genetic approach. One branch of this approach was to
use a TK2 mutant, dlsptk. Following corneal inoculation
f mice, dlsptk, like other TK2 deletion mutants (Coen et
al., 1989; Chen et al., 1998; Horsburgh et al., 1998),
replicates to wild type (wt) titers on the eye at 24 h p.i.
Consistent with this observation, during the first ;30 h
p.i., similar numbers of genomes accumulate in wt- and
in dlsptk-infected trigeminal ganglia (Kramer et al., 1998).
At 48 h p.i., TK2 mutants exhibit variable titers on the eye,
ranging from those of wt virus (e.g., Kramer et al., 1998)
to substantially lower titers (e.g., Coen et al., 1989). At
subsequent times p.i., the titers of these mutants decline
more quickly than those of wt strains (Coen et al., 1989;
Chen et al., 1998; Thompson and Sawtell, 2000). Of par-
ticular importance for the present study, dlsptk does not
detectably replicate in trigeminal ganglia during the
acute phase of infection nor does it reactivate upon
ganglionic explant, even when inoculated at high doses
(Coen et al., 1989; Kramer et al., 1998; Horsburgh et al.,
1998). However, dlsptk does express transcripts from
productive cycle genes during latent infection (Kramer
and Coen, 1995). Thus, if viral reactivation is required for
persistent expression of cytokines, such expression
should be lacking in dlsptk-infected ganglia. If, however,
antigen expression in the absence of reactivation is
sufficient for persistent expression of cytokines, such
expression should be observed in dlsptk-infected gan-
glia.
To further address the role of viral gene expression in
cytokine expression, we also examined the effects of a
LAT deletion mutation, which reduces expression of the
major LAT species by 105- to 106-fold and leads to in-
creased levels of productive cycle transcripts in ganglia
(Chen et al., 1997; Garber et al., 1997). We compared the
evels of interferon (IFN)-g and tumor necrosis factor
(TNF)-a transcripts in ganglia latently infected with
dlsptk, LAT deletion mutants, and wt virus. Our results
argue that neither HSV replication, the ability to reacti-
vate, nor LAT expression in ganglia is required for per-
sistent, elevated cytokine gene expression. We suggest
that low levels of productive cycle gene products providesignals that elicit cytokine expression long after infec-
tious virus can be detected.
RESULTS
Kinetics of viral DNA accumulation in the absence of
ganglionic replication
To verify the ganglionic replication defect of dlsptk in
the experiments reported here, we titered virus on Day
3 p.i. in ganglionic homogenates from mice infected with
either KOS or dlsptk. The mean titer of infectious virus
produced in KOS-infected trigeminal ganglia was 8 3 105
plaque-forming units (PFU)/ganglion; no virus was de-
tected in dlsptk-infected ganglia. We also examined the
amount of viral DNA in ganglia using quantitative PCR
assays. The mean number of viral genomes in KOS-
infected trigeminal ganglia on Day 3 p.i. was about 103-
fold higher than in dlsptk-infected ganglia (Fig. 1), similar
to previous results with this virus and other TK2 mutants
following corneal inoculation (Kramer et al., 1998;
hompson and Sawtell, 2000). Consistent with previous
esults (Kramer et al., 1998) the levels of viral DNA in
OS-infected ganglia decreased substantially after Day
p.i., and remained relatively constant at ;104 copies
per ganglion from Day 15 to Day 100 p.i. (Fig. 1) and even
to Day 150 p.i. (data not shown). In dlsptk-infected gan-
3
FIG. 1. Kinetics of accumulation of viral DNA in trigeminal ganglia.
Mice were infected with either wt strain KOS (closed squares) or
mutant dlsptk (closed diamonds). Trigeminal ganglia were harvested at
the indicated times p.i. and the amount of HSV DNA normalized to the
amount of cellular DNA was determined for each ganglion. Each point
represents mean log10 HSV DNA per ganglion with standard errors of
he mean represented as error bars. The results are compiled from
hree separate experiments. The number of ganglia assayed at each
ime point is indicated in parentheses.glia, the levels of viral DNA remained constant at ;10
copies per ganglion from Day 3 to Day 100 p.i. (Fig. 1).
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209CYTOKINE EXPRESSION IN GANGLIA WITHOUT HSV REPLICATIONAccordingly, the mean viral genome copies in dlsptk-
infected ganglia were, on average, about 10-fold lower
than those in KOS-infected ganglia from Day 15 on,
similar to our previous reports (Kramer and Coen, 1995;
Kramer et al., 1998). Thus, in the present studies, dlsptk
did not replicate detectably in ganglia.
Induction of IFN-g transcripts in the absence of
ganglionic replication
We assayed ganglia from mice infected with either
KOS or dlsptk for IFN-g transcripts using a quantitative
T-PCR assay in which the number of cytokine tran-
cripts in ganglia was compared with a standard curve
stablished using known amounts of synthetic tran-
cripts mixed with mouse brain RNA. Yields of ganglionic
NA were normalized using the amount of cellular b-ac-
tin RNA, as described previously (Kramer and Coen,
1995). As shown in Fig. 2A, the assay was linear through
several orders of magnitude and it was sensitive, with a
limit of detection of ;2 3 102 transcripts per ganglion.
Using this assay, the amount of IFN-g mRNA was
below the limit of detection in about 50% of ganglia from
mock-infected mice (examples in Fig. 2A) at all time
points examined. Using the conservative assumption
that ganglia in which we did not detect IFN-g mRNA
nonetheless contained ;2 3 102 transcripts per gan-
FIG. 2. Quantitative RT-PCR assays of cytokine transcripts. Assay
enerated using the IFN-1 and IFN-2 primer pair (A) or TNF-1 and TNF-
he IFN-3 oligonucleotide (A) or the TNF-3 oligonucleotide (B and C). S
PCR-mTNF (B and C) prepared with 5 mg of mouse brain RNA (A and B
right) were reacted with (1) or without (2) reverse transcriptase (RT
“Standard” refers to the number of synthetic transcript molecules (indi
The sizes of the RT-PCR products are indicated at the right. In each of
30 days p.i. from mock-infected (mock), dlsptk-, KOS-, or KdlLAT1.8-infec
infI and end-labeled with 32P).lion (the assay’s limit of detection), mock-infected gan-
lia contained, on average, ;8 3 102 transcripts perganglion (Fig. 3). Using the less-conservative assump-
tion that ganglia in which we did not detect IFN-g mRNA
contained none, mock-infected ganglia contained, on
average, ;6 3 102 transcripts per ganglion. For drawing
figures and for statistical analyses, we used the more
conservative assumption. In KOS-infected ganglia, a ma-
jor induction (;104-fold) of IFN-g transcripts to 5 3 106
transcripts per ganglion was observed at 3 days p.i. (Fig.
3). This is consistent with previous studies using other
strains of HSV-1 where induction of IFN-g and IFN-g
transcripts during acute ganglionic infection was ob-
served (Cantin et al., 1995; Halford et al., 1996; Liu et al.,
996; Shimeld et al., 1997) and quantifies this induction.
The levels of IFN-g mRNA in KOS-infected ganglia
ecreased gradually after 3 days p.i., but remained ele-
ated through 100 days p.i. (Fig. 3) and even up to Day
50 p.i. (Table 1), when there were ;104 transcripts/
ganglion. This persistent expression of IFN-g mRNA is
onsistent with previous studies of IFN-g and IFN-g
transcripts using other strains of HSV-1 (Cantin et al.,
1995; Liu et al., 1996; Halford et al.,1996; Shimeld et al.,
997), although there are some differences among the
arious studies regarding the kinetics of expression.
In dlsptk-infected ganglia, although levels of IFN-g
transcripts were lower than those in KOS-infected gan-
glia, they were higher than those in mock-infected gan-
g transcripts (A) and TNF-a transcripts (B and C). RT-PCR products
d C) were separated on polyacrylamide gels, blotted, and probed with
transcript mixes derived by in vitro transcription of pBSK-IFN-g (A) or
r without mouse brain RNA (C), or individual ganglion RNAs (A and B,
the products displayed in adjacent lanes. In each of the left panels,
bove the lanes) assayed in each reaction; B indicates a water blank.
ht panels, samples were derived from individual ganglia harvested at
e, as indicated. M, molecular weight marker (fX174 DNA digested withof IFN-
2 (B an
ynthetic
, left) o
), and
cated a
the rig
ted micglia by Day 3 p.i. (Figs. 2A and 3) and they remained
elevated through 100 days p.i. (Fig. 3). On average, they
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210 CHEN ET AL.were eightfold (using the more conservative assumption)
to 10-fold higher than those in mock-infected trigeminal
ganglia from Day 3 to Day 100 p.i. (P , 0.05, Student’s t
est, over the length of the experiment, from Day 15 or
ay 30 to Day 100, and at specific time points).
FIG. 3. Kinetics of IFN-g mRNA accumulation in TG following cornea
wt strain KOS (closed squares) or mutant dlsptk (closed diamonds). Tri
IFN-g mRNA normalized to the amount of cellular RNA was determined
Each point represents mean log10 IFN-g mRNA per ganglion with stan
ssayed at each time point is indicated in parentheses. The limit of dete
t 2.3 log10 transcripts per ganglion. For calculating means and for statis
to detect IFN-g transcripts were assigned conservatively as the limit o
in dlsptk-infected trigeminal ganglia is significantly elevated above tho
ntire time course, as well as from Day 15 or 30 to Day 100, the numb
elevated above those in mock-infected trigeminal ganglia (P , 0.05, S
TABLE 1
IFN-g mRNA in Latently Infected Ganglia
Time post
infection
IFN-g mRNA/TG (log mean 6 SE)a
in ganglia infected with
KOS KdlLAT1.8 KFSLAT1
Day 3 6.7 6 0.1 (9)b 6.1 6 0.3 (9) 6.5 6 0.1 (8)
ay 15 5.6 6 0.2 (9) 5.7 6 0.1 (10) 5.9 6 0.1 (9)
ay 30 5.1 6 0.2 (29) 4.8 6 0.2 (20) 4.6 6 0.2 (19)
ay 60 4.3 6 0.2 (6) 3.8 6 0.4 (7) 4.6 6 0.2 (8)
ay 100 3.9 6 0.3 (9) 4.0 6 0.2 (10) 4.2 6 0.2 (9)
ay 150 4.3 6 0.3 (11) 4.2 6 0.2 (11) 4.3 6 0.2 (9)
ay 3–150 5.0 6 0.1 (73) 4.8 6 0.1 (67) 4.9 6 0.1 (62)
a Calculated by averaging the logs of the means. TG 5 trigeminal
anglion; SE 5 standard error of the mean.
b The total number of ganglia assayed for each group is in paren-
theses.Kinetics of TNF-a mRNA accumulation in the absence
f ganglionic replication
A sensitive and quantitative RT-PCR assay was simi-
arly established for TNF-a transcripts. In this case, using
ur standard reconstruction conditions that include
ouse brain RNA, we detected a signal in the absence
f synthetic TNF-a transcripts (Fig. 2B). This signal was
the result of TNF-a transcripts in mouse brain RNA, as it
was absent when the synthetic transcripts were assayed
without mouse RNA (Fig. 2C). The average limit of de-
tection of this assay was ;6 3 102 transcripts (data not
hown). In mock-infected ganglia, low levels of TNF-a
mRNA, which were very close to the limit of detection for
this assay, were detected in about 75% of samples at all
time points following infection (example in Fig. 2B). In
about 25% of mock-infected ganglia, the levels were
below the limit of detection (example in Fig. 2B). In
KOS-infected ganglia, much higher levels of TNF-a tran-
cripts were observed than in mock-infected ganglia. At
days p.i., the levels of these transcripts exceeded 106
per ganglion and they remained between 105 and 106 per
ganglion through 60 days p.i., although they dropped to
ation. Mice were either mock-infected (closed circles), or infected with
l ganglia were harvested at the indicated times p.i. and the amount of
h ganglion. The results are compiled from three separate experiments.
rrors of the mean represented as error bars. The number of ganglia
or the assay is indicated by the horizontal line intersecting the ordinate
nalyses, the values for mock-infected ganglia in which we were unable
tion. * indicates time points at which the number of IFN-g transcripts
ock-infected trigeminal ganglia (P , 0.05, Student’s t test). Over the
N-g transcripts in dlsptk-infected trigeminal ganglia was significantly
s t test).l inocul
gemina
for eac
dard e
ction f
tical a
f detec
se in mbetween 104 and 105 by Day 150 (Table 2). This induction
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211CYTOKINE EXPRESSION IN GANGLIA WITHOUT HSV REPLICATIONand persistence of TNF-a expression is consistent with
ost previous reports using other wt strains of virus
Cantin et al., 1995; Halford et al., 1996; Liu et al., 1996).
In dlsptk-infected ganglia, similar to what was ob-
erved for IFN-g mRNA accumulation, TNF-a transcripts
were induced by 3 days p.i. and remained elevated over
the levels in mock-infected ganglia through Day 100 p.i.
(Fig. 4). The levels of TNF-a transcripts were lower than
those in KOS-infected trigeminal ganglia (Table 2), al-
though they were, on average, eight- to ninefold higher
than in mock-infected TG from Day 3 to Day 100 p.i. (P ,
0.05, Student’s t test, over the length of the experiment,
rom Day 15 or Day 30 to Day 100, and at specific time
oints). This value is very similar to that observed for
FN-g transcripts.
he effect of a LAT deletion on the kinetics of
ytokine mRNA accumulation
In previous studies, we found that a LAT deletion
utation essentially eliminates expression of major LAT
pecies and increases expression of ICP4 and tk tran-
cripts in ganglia (Chen et al., 1997; Garber et al., 1997).
e wondered whether the decrease in LATs would re-
uce cytokine gene expression or whether the increased
xpression of productive cycle genes might further stim-
late cytokine gene expression. Therefore, we investi-
ated the accumulation of cytokine mRNA in ganglia
nfected with LAT deletion mutants. In an initial experi-
ent, we compared the mutant dlLAT1.8 (Leib et al.,
989a) with wt strain KOS in 10 ganglia latently infected
ith each virus. Similar to our previous results (Chen et
l., 1997), at Day 30 p.i. the mean levels of LATs were
educed 105- to 106-fold, whereas ICP4 and tk transcripts
er viral genome in the dlLAT1.8-infected ganglia were
ive- to 10-fold higher than those in the KOS-infected
anglia (data not shown). However, the levels of IFN-g
TABLE 2
TNF-a mRNA in Latently Infected Ganglia
Time post
infection
TNF-a mRNA/TG (log mean 6 SE)a
in ganglia infected with
KOS KdlLAT1.8 KFSLAT1
Day 3 6.4 6 0.1 (9)b 5.2 6 0.4 (9) 5.7 6 0.3 (8)
Day 15 5.6 6 0.2 (9) 5.4 6 0.1 (10) 5.9 6 0.1 (9)
Day 30 5.3 6 0.2 (29) 5.1 6 0.1 (20) 5.0 6 0.2 (19)
Day 60 6.0 6 0.2 (6) 4.8 6 0.4 (7) 6.0 6 0.1 (8)
Day 150 4.4 6 0.3 (9) 3.8 6 0.3 (11) 3.7 6 0.3 (10)
Days 3–150 5.4 6 0.1 (62) 4.9 6 0.1 (57) 5.2 6 0.1 (54)
a Calculated by averaging the logs of the means. TG 5 trigeminal
anglion. SE 5 standard error of the mean.
b The total number of ganglia assayed for each group is in paren-
theses.and TNF-a transcripts were no higher in dlLAT1.8-in-
fected than in KOS-infected ganglia, but were possiblylower [IFN-g mRNA, average 3.5 6 1.1 3 105 copies/
anglion (dlLAT1.8) vs 5 6 1 3 105 (KOS); TNF-a mRNA,
verage 1 6 0.3 3 105 copies/ganglion (dlLAT1.8) vs 9 6
3 105 (KOS)].
To further investigate this initial finding, we infected
ice with KdlLAT1.8 (Garber et al., 1997), which is de-
ived from KOS and has the same deletion as dlLAT1.8, a
irus in which the KdlLAT1.8 deletion was rescued by wt
equences, KFSLAT1, or KOS. Similar amounts of DNA
accumulated in ganglia latently infected with each of the
viruses at 30 days p.i. [5.0 6 0.1 3 103 copies/ganglion
(KdlLAT1.8); 4.0 6 0.1 3 103 (KFSLAT1); 5.0 6 0.1 3 103
(KOS)]. Consistent with our previous study (Chen et al.,
1997), the deletion mutation resulted in an approximately
106-fold reduction in the expression of LATs and a five- to
0-fold increase, on average, in the accumulation of ICP4
nd tk transcripts per viral genome at 30 days p.i. (data
ot shown). There were no major differences and cer-
ainly no increase in levels of IFN-g (Table 1) or TNF-a
transcripts (Table 2) in trigeminal ganglia latently in-
FIG. 4. Kinetics of TNF-a mRNA accumulation in TG following cor-
neal inoculation. Mice were either mock-infected (closed circles) or
infected with mutant dlsptk (closed diamonds). Trigeminal ganglia were
harvested at the indicated times p.i. and the amount of TNF-a mRNA
ormalized to the amount of cellular RNA was determined for each
anglion. The results are compiled from three separate experiments.
ach point represents mean log10 TNF-a mRNA per ganglion with
standard errors of the mean represented as error bars. The number of
ganglia assayed at each time point is indicated in parentheses. The
limit of detection for the assay is indicated by the horizontal line
intersecting the ordinate at 2.8 log10 transcripts per ganglion. For
calculating means and for statistical analyses, the values for mock-
infected ganglia in which we were unable to detect TNF-a transcripts
were assigned conservatively as the limit of detection. * indicates time
points at which the number of TNF-a transcripts in dlsptk-infected
trigeminal ganglia is significantly elevated above those in mock-in-
fected TG (P , 0.05, Student’s t test). Over the entire time course, as
well as from Day 15 or 30 to Day 100, the number of TNF-a transcripts
in dlsptk-infected trigeminal ganglia was significantly elevated above
those in mock-infected trigeminal ganglia (P , 0.05, Student’s t test).
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212 CHEN ET AL.fected with the LAT deletion mutant compared with those
latently infected with KOS or the rescued virus at any
particular time point, except perhaps on Day 60, at which
time ganglia infected with the deletion mutant appeared
to exhibit less TNF-a expression. If one averages values
ver the entire time course, again ganglia infected with
he deletion mutant appeared to contain slightly fewer
NF-a transcripts (Tables 1 and 2). Regardless, neither
the loss of LATs nor the increased expression of viral
genes resulting from the loss of LATs had a substantial
effect on expression of these cytokines in ganglia.
DISCUSSION
Induction of cytokine expression in dlsptk-infected
ganglia
By 3 days p.i. transcripts for both IFN-g and TNF-a in
trigeminal ganglia were induced eight- to 10-fold by
dlsptk infection, despite the failure of this virus to repli-
cate in ganglia. Expression of productive cycle genes by
TK2 viruses during acute infection of ganglia is much
reater than that of wt virus during latency as measured
y RT-PCR (Kramer et al., 1998). Additionally, certain
productive cycle proteins have been detected immuno-
histochemically in a small number of neurons in ganglia
acutely infected with a TK2 mutant (Thompson and Saw-
tell, 2000). Thus, there is evidence for activities of TK2
mutants that could explain their ability to induce expres-
sion of cytokine transcripts.
Using antibody staining, Walev et al. (1995) failed to
detect any induction of cytokine expression by a different
tk mutant. This difference between their results and ours
probably reflects the greater sensitivity of RT-PCR vs
immunohistochemistry in detecting cytokine expression.
Persistence of cytokine expression in latently infected
ganglia does not require the ability to reactivate
The 8- to 10-fold elevation in IFN-g and TNF-a tran-
cripts induced in ganglia by dlsptk persisted for months.
ollowing high-dose corneal inoculation, this virus fails
o reactivate upon the extreme stimulus of axotomy and
xplant (Coen et al., 1989; Kramer et al., 1998; Horsburgh
t al., 1998). Despite this, it could be argued that dlsptk
ight nonetheless reactivate in mice. However, even
train KOS, the wt parent of this mutant fails to exhibit
pontaneous reactivation in mice and is highly impaired
or reactivation in mice following UV irradiation (Strelow
t al., 1994; D. Leib, personal communication). We thus
onclude that persistent elevation of cytokine expression
oes not require viral replication or the ability to reacti-
ate.
The defect of TK2 mutants for ganglionic replication
and reactivation appears to be at the level of DNA rep-
lication, as these viruses do not exhibit exponential am-
plification of viral DNA and are defective for late geneexpression during acute ganglionic infection (Kramer et
al., 1998; Thompson and Sawtell, 2000). Moreover, the
defects of these viruses for ganglionic replication and
reactivation can be rescued by the human thymidine
kinase gene (Chen et al., 1998), consistent with the
widely accepted idea that HSV TK functions to supply
nucleotide precursors for DNA replication. Thus, our re-
sults strongly suggest that persistent elevated expres-
sion of cytokine genes does not require viral DNA repli-
cation.
Halford et al. (1997) reported that acyclovir, an inhibitor
of HSV DNA replication, reduced expression of IFN-g
and TNF-a transcripts in ganglia at 120 days p.i. There
re several considerations that might reconcile this re-
ult with ours, including the use of HSV-1 strain McKrae.
nlike strain KOS, McKrae exhibits spontaneous reacti-
ation in latently infected mice (Willey et al., 1984). Thus,
cytokine expression in McKrae-infected, but not in KOS-
infected, ganglia might require replication. Additionally,
high concentrations of acyclovir [the dose/kg used was
higher than that administered to humans and acyclovir is
more orally available in mice than in humans (deMiranda
and Good, 1992)] can inhibit certain immune functions
(Kankova´-Vancurova´ et al., 1990; Quinn et al., 1982) and
induce neurotoxicity (Adair et al., 1994). These effects on
neuronal and immune cell metabolism, rather than spe-
cific effects on HSV replication, might in theory account
for the reduced expression of cytokine transcripts in
ganglia.
It is also possible that viral DNA replication contrib-
utes to persistent expression of cytokines without being
required for it. High-dose acyclovir did not reduce cyto-
kine expression at Days 35 and 60 p.i. Even at Day
120 p.i., cytokine transcripts were not decreased to the
levels observed in uninfected mice (Halford et al., 1997).
Interestingly, in our study no obvious decrease in levels
of cytokine transcripts was detected in dlsptk-infected
ganglia from Day 30 to Day 100, while in wt-infected
ganglia a decrease was apparent. Moreover, the levels
of cytokine transcripts observed in dlsptk-infected gan-
glia were lower than those in wt-infected ganglia (how-
ever, see below). If DNA replication contributes to the
level of cytokine expression observed in wt-infected gan-
glia, this could be a consequence, as suggested by
Halford et al. (1997), of viral reactivation or late gene (e.g.,
glycoprotein) expression, which depends on DNA repli-
cation. Regardless, our results argue strongly that DNA
replication is not required for persistent, elevated cyto-
kine expression.
What causes persistent cytokine expression in
latently infected ganglia?
Given that the cellular immune response responsible
for cytokine expression ordinarily wanes rapidly follow-
ing disappearance of viral antigen (Doherty and Ahmed,
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213CYTOKINE EXPRESSION IN GANGLIA WITHOUT HSV REPLICATION1999; Slifka et al., 1999), the simplest explanation for
persistent cytokine expression is persistent expression
of viral antigens in latently infected ganglia. However,
despite occasional published exceptions (e.g., Green et
al., 1981), investigators have not succeeded in reproduc-
ibly detecting viral proteins in these ganglia. Techniques
for detecting viral proteins, however, are much less sen-
sitive than those for detecting viral nucleic acids. Viral
DNAs and RNAs, including productive cycle transcripts,
are readily detected in latently infected ganglia (Rock
and Fraser, 1983; Stevens et al., 1987; Kramer and Coen,
1995; Chen et al., 1997; Kramer et al., 1998). Because
nucleic acids are generally poor antigens, it seems most
likely that protein products derived from such transcripts
provide the antigenic stimuli for immune cells to produce
cytokines in latently infected trigeminal ganglia.
One possible source of viral proteins is the LAT tran-
scription unit. However, in agreement with the results of
Carr et al. (1998), we found that a LAT deletion (which
differs by only 24 bp from that studied by Carr et al.) did
not eliminate the persistent elevation of cytokine expres-
sion in ganglia. Our results extend those of Carr et al.
(1998) in that the LAT deletion studied here was docu-
mented by RT-PCR to essentially eliminate LATs (Chen et
al., 1997), is in strain KOS rather than in strain McKrae
(see comments above), and its effects on cytokine ex-
pression were examined for 150 rather than 60 days,
arguing against residual effects of the acute phase of
infection. Thus, in agreement with Carr et al. (1998), we
conclude that RNA or protein products of the LAT tran-
scription unit are not required for persistent elevation of
cytokine expression.
That leaves productive cycle proteins as the source of
antigen. Transcripts from the ICP4 and tk genes are
expressed in ganglia latently infected with HSV (Kramer
and Coen, 1995; Chen et al., 1997). In ganglia latently
infected with dlsptk, wt levels of expression of these
transcripts per viral genome can be observed (Kramer
and Coen, 1995). Whether most latently infected cells
express low levels of productive cycle transcripts or
whether a few such cells express relatively high levels of
these transcripts is not clear. This question deserves
further study. Regardless, the results reported here pro-
vide indirect evidence that productive cycle transcripts
are translated into proteins and that these proteins pro-
vide antigenic signals. This view is also favored by in-
vestigators in a recent study that reported inhibition of
HSV reactivation by CD81 T cells that are retained in
latently infected ganglia (Liu et al., 2000).
How could antigen expression in latently infected
neurons elicit cytokine expression?
How could productive cycle proteins in latently in-
fected neurons elicit cytokine expression? Although HSV
has been shown to induce MHC I transcripts and cell- psurface protein in sensory neurons during acute gangli-
onic infection (Pereira et al., 1994; Pereira and Simmons,
1999), MHC I expression was not observed in latently
infected ganglia in these studies using in situ hybridiza-
tion and rosetting assays. It is possible, however, that
these methods were insufficiently sensitive to detect
low-density expression of MHC I on latently infected
neurons, which could present productive cycle antigens
to the immune system, e.g., CD81 T cells (Liu et al.,
000). It is also possible that productive cycle antigens
licit cytokine expression via recognition of neurons by
gd T-cell-receptor-expressing cells, which produce cyto-
ines (Sciammas et al., 1994; Liu et al., 1996; Kodukula et
al., 1999), or by trafficking to cells that are known to
express MHC and cytokines such as satellite cells
(Shimeld et al., 1997). These various possibilities make
testable predictions.
Levels of cytokines in ganglia infected with TK2 and
LAT2 mutants
Aside from the ;10-fold fewer genomes per ganglion
Fig. 1) and, accordingly, fewer productive cycle tran-
cripts per ganglion (Kramer and Coen, 1995), there are
ive- to 10-fold fewer latently infected cells in TK2 mutant-
infected than in wt-infected ganglia (Coen et al., 1989;
Jacobson et al., 1993; Thompson and Sawtell, 2000).
These reductions may account for the similar fold-reduc-
tions in cytokine expression in ganglia latently infected
with dlsptk.
By extension, LAT2 mutants, which exhibit increased
xpression of productive cycle transcripts, might be ex-
ected to produce higher levels of cytokine-inducing
iral proteins. However, no increases in cytokine expres-
ion were observed. Perhaps, because of saturable pro-
esses of antigen presentation (e.g., low-density MHC
xpression), the amount of cytokine produced is propor-
ional to the number of latently infected cells, rather than
o the total amount of expression of productive cell an-
igens. Indeed, LAT2 mutants have wt or fewer numbers
of viral genomes and latently infected cells per ganglion
(this study; Chen et al., 1997; Thompson and Sawtell,
1997). However, other explanations are possible.
We previously raised the possibility that reduced re-
activation of certain LAT2 mutants following explant
could be the result, at least in part, of LATs normally
repressing productive cycle genes that would otherwise
elicit infiltration of immune cells (Chen et al., 1997). That
could predict higher levels of cytokines in ganglia in-
fected with LAT2 mutants. That simple prediction was
not met. What accounts for the reactivation defects of
LAT2 mutants remains controversial.
mplications for maintenance of latencyMost cytokine actions can be attributed to an altered
attern of gene expression in their target cells and there
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214 CHEN ET AL.is evidence that particular cytokines inhibit HSV, at least
in part, by inhibiting viral gene expression (reviewed in
Vilcek and Sen, 1996). It has been hypothesized by sev-
eral investigators (e.g., Liu et al., 1996; Halford et al.,
1996; Cantin et al., 1995) that cytokines help maintain
latency. There is ample evidence that cytokines are im-
portant for controlling acute-phase HSV replication and
viral reactivation, but no single cytokine or simple com-
bination of cytokines has been shown to be necessary or
sufficient to maintain latency, once established
(Kodukula et al., 1999; Cantin et al., 1999; Su et al., 1990;
Leib et al., 1999; Lekstrom-Himes et al., 2000; Ellison et
al., 2000; D. Leib, personal communication). We previ-
ously showed that a viral function associated with the
LAT locus helps to maintain latency by repressing pro-
ductive cycle gene expression, but also that this was
neither necessary nor sufficient to maintain latency
(Chen et al., 1997). It seems likely that there are numer-
ous redundancies in viral, cellular, and immune mecha-
nisms that are involved in maintaining HSV latency.
MATERIALS AND METHODS
Viruses and cells
Wild type (wt) HSV-1 strain KOS, TK2 deletion mutant,
lstpk (Coen et al., 1989), LAT deletion mutants, dlLAT1.8
nd KdlLAT1.8, and the marker-rescued derivative of
dlLAT1.8, KFSLAT1 (Garber et al., 1997; Leib et al.,
989a) were propagated and assayed on Vero cell mono-
ayers as previously described (Coen et al., 1985).
nfection of mice and tissue collection
Eight-week-old male CD-1 (Charles River Laboratory,
ilmington, MA) or CD-1-derived Hsd:ICR mice (Harlan
prague–Dawley, Indianapolis, IN) were anesthetized
nd then inoculated with 2 3 106 PFU per eye of a
articular virus or mock-infected with virus diluent fol-
owing corneal scarification as previously described
T
Primer
Genes Oligonucleotidea
IFN-g IFN-1 CTA
IFN-2 AGA
IFN-3b CAT
TNF-a TNF-1b GCC
TNF-2b TTG
TNF-3 GGT
a Designations indicate the following: 1, upstream primer; 2, downst
b The IFN-3 sequence was that used previously by Cantin et al. (199Leib et al., 1989b). At various days p.i., individual trigem-
nal ganglia were harvested, rapidly frozen in liquid ni-rogen, and homogenized in guanidine thiocyanate
Kramer and Coen, 1995).
xtraction of nucleic acids and reverse transcription
One-tenth of each ganglion homogenate was pro-
essed for viral DNA and cellular DNA as described
Kramer and Coen, 1995). The remainder was treated
ith DNase and reverse transcribed in the presence of
ouse cytokine-specific (IFN-2, TNF-2) (Table 3), mouse-
pecific (Act-2), and virus-specific (LAT-2, 4-2, tk-2) prim-
rs as previously described (Kramer and Coen, 1995).
liquots of cDNA were assayed by PCR.
NA standards
Transcription plasmids for generating RNA quantifica-
ion standards from the mouse b-actin (pSPMbA), ICP4
(pKS159ICP4), tk (pSVtk), and LAT (pKS159LAT) genes
were previously described (Kramer and Coen, 1995).
Additionally, plasmid pBSK-IFN-g was constructed by
cloning a 1.4-kb BamHI–BamHI fragment of mouse IFN-g
cDNA (Dranoff et al., 1993; kindly provided by G. Dranoff)
into Bluescript II SK2 (Stratagene, La Jolla, CA), placing it
under the control of bacterial T3 promoter. Plasmid PCR-
mTNF, which contains a mouse TNF-a cDNA fragment
(502 bp) in pCRscript (Stratagene), placing it under the
control of bacterial T7 promoter (Lausch et al., 1996), was
kindly provided by Y.-H. Su. RNA was transcribed in the
presence of labeled GTP and quantified as previously
described (Kramer and Coen, 1995). Unless otherwise
indicated, serial dilutions of synthetic transcript stan-
dards were reconstituted with mouse brain RNA and
processed concomitantly with samples.
PCR
PCR for mouse adipsin and actin cDNAs and for virus-
specific cDNAs, ICP4, tk, and LAT was performed essen-
tially as previously described (Kramer and Coen, 1995).
robes
quence (59 to 39)
Primer pair and
product size (nt)
TCTGAATAACTATTTTAAC 1–2,145
AGGTAGAAAGAGATAATC
TCCTGCAGAGCC
CCCACGTCGTAG 1–2,383
ATTGACCTCAGC
CTTGTCTACTCC
rimer; 3, internal probe.
the TNF-1 and -2 sequences were those used by Halford et al. (1996).ABLE 3
s and P
Se
GAAAG
GTCTG
GAAAA
TGTAG
GGCAG
TGTACPrimers and probes for mouse IFN-g and TNF-a are
listed in Table 3. The IFN-g reaction mixtures contained
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215CYTOKINE EXPRESSION IN GANGLIA WITHOUT HSV REPLICATION4.5 mM Mg21 and were annealed at 55°C, and TNF-a
reaction mixtures contained 1.5 mM Mg21 and were an-
nealed at 60°C. The rest of the PCR components for
these two assays were the same as those of other
assays (Kramer and Coen, 1995). cDNA for both cyto-
kines were PCR amplified 30 cycles using the conditions
previously described (Kramer and Coen, 1995). Positive
and negative controls were included in each amplifica-
tion. Product specificity for both cytokine sequences am-
plified from infected tissues was verified by product size,
hybridization with the internal oligonucleotide probe, and
restriction enzyme analysis.
Detection and quantification of PCR products
PCR products were separated by electrophoresis on
polyacrylamide gels, and gels were transferred, probed,
and quantified using a phosphorimager (Kramer and
Coen, 1995), except that amounts of adipsin PCR prod-
ucts and b-actin RT-PCR products were quantified by
analysis of gels stained with SYBR Green I (Molecular
Probes, Eugene, OR) using a FluorImager (Molecular
Dynamics, Sunnyvale, CA).
Normalization of viral DNA and RNA
For each sample, the amount of viral DNA was nor-
malized to cellular DNA encoding adipsin and the
amounts of viral and cytokine mRNAs were normalized to
cellular mRNA encoding b-actin and calculated on a per
anglion basis as described previously (Chen et al.,
997; Kramer and Coen, 1995).
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